We are live on ! Find out more
FP

Flagship Pioneering Portfolio holdings

AUM $1.16B
1-Year Est. Return 67.93%
This Fund
S&P 500
This Quarter Est. Return
-29.95%
1 Year Est. Return
+67.93%
3 Year Est. Return
-39.17%
5 Year Est. Return
-45.89%
10 Year Est. Return
–
AUM
$366M
AUM Growth
–
Cap. Flow
+$441M
Cap. Flow %
120.47%
Top 10 Hldgs %
100%
Holding
7
New
7
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
MCRB icon
Seres Therapeutics
MCRB
+$223M
2
EDIT icon
Editas Medicine
EDIT
+$70.8M
3
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
+$61M
4
AGIO icon
Agios Pharmaceuticals
AGIO
+$42M
5
RNAC icon
Cartesian Therapeutics
RNAC
+$21.5M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 95.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCRB icon
1
Seres Therapeutics
MCRB
$48.1M
$156M 42.59%
+634,144
New +$223M
SYRS
2
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$66.7M 18.22%
+480,666
New +$61M
AGIO icon
3
Agios Pharmaceuticals
AGIO
$2.16B
$51M 13.93%
+965,369
New +$42M
EDIT icon
4
Editas Medicine
EDIT
$399M
$46.6M 12.73%
+3,455,316
New +$70.8M
RNAC icon
5
Cartesian Therapeutics
RNAC
$232M
$23.5M 6.43%
+55,062
New +$21.5M
TTOO
6
DELISTED
T2 Biosystems, Inc
TTOO
$15.8M 4.3%
+435
New +$14.3M
CARM
7
DELISTED
Carisma Therapeutics
CARM
$6.59M 1.8%
+117,736
New +$8.77M

Similar funds

AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
BI
Bramshill Investments Naples, Florida $1.16B AUM 0.86% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
SFG
SNS Financial Group Minneapolis, Minnesota $1.16B AUM 13.88% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
FFP
FourThought Financial Partners Venice, Florida $1.16B AUM 24.95% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Flagship Pioneering's Q3 2016 Portfolio in Review

Q3 2016 is the first quarter with a 13F filing on record for Flagship Pioneering, which disclosed 7 positions worth $366M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Seres Therapeutics: 634,144 shares worth $156M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets.

  • Flagship Pioneering's largest Q3 2016 buy was Seres Therapeutics: 634,144 shares worth $156M.
  • Flagship Pioneering's ten largest holdings make up 100% of its $366M portfolio in Q3 2016.
  • Flagship Pioneering disclosed 7 positions in Q3 2016, its first 13F filing on record.

Based on Flagship Pioneering's 13F filing for Q3 2016, filed 14 Nov 2016.